Nothing Special   »   [go: up one dir, main page]

Feng et al., 1996 - Google Patents

Vascular alpha-2 adrenoceptor function is decreased in rats with congestive heart failure

Feng et al., 1996

View PDF
Document ID
11525577530527143728
Author
Feng Q
Bergdahl A
Lu X
Sun X
Edvinsson L
Hedner T
Publication year
Publication venue
Cardiovascular research

External Links

Snippet

Objective: Vascular alpha-2 adrenoceptor function of rats with congestive heart failure (CHF) was characterized in both in vivo and in vitro experiments. Methods: CHF was induced in Sprague-Dawley rats by coronary artery ligation. Sham-operated rats served as normal …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons

Similar Documents

Publication Publication Date Title
Kapusta et al. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)
Palatini et al. Association of tachycardia with morbidity and mortality: pathophysiological considerations.
King et al. Endothelin: a potent renal and systemic vasoconstrictor peptide
Richards et al. Plasma alpha natriuretic peptide in cardiac impairment.
Quigg et al. Mechanism of the attenuated peak heart rate response to exercise after orthotopic cardiac transplantation
Gunning et al. Atrial natriuretic peptide (31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2.
Roth et al. Altered hepatic vasopressin and alpha 1-adrenergic receptors after chronic endotoxin infusion
Massingham et al. The role of presynaptic receptors in the cardiovascular actions of N, N-di-n-propyldopamine in the cat and dog
Salomonsson et al. Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration
Rajs et al. Cardiac lesions in intravenous drug addicts
Fontana et al. Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure
Mathai et al. Central losartan blocks natriuretic, vasopressin, and pressor responses to central hypertonic NaCl in sheep
Feng et al. Vascular alpha-2 adrenoceptor function is decreased in rats with congestive heart failure
Johnson et al. Pressor responses to vasopressin in rabbits with 3-day renal artery stenosis
Nishida et al. Suppression of renal sympathetic nerve activity during portal vein infusion of hypertonic saline
Wilkes et al. Glomerular endothelin receptors during initiation and maintenance of ischemic acute renal failure in rats
Haass et al. Role of autonomic nervous system and vasoactive hormones in the release of atrial natriuretic peptides in conscious rats
Akins et al. Brain histamine regulates pressor responses to peripheral hyperosmolality
Vesely et al. Elevated atrial natriuretic peptides and early renal failure in type 2 diabetic Goto-Kakizaki rats
Malmström et al. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo
Liard cAMP and extrarenal vasopressin V2 receptors in dogs
Ullman et al. Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction
Weber et al. Naloxone improves functional recovery of myocardial stunning in conscious dogs through its action on the central nervous system
Fromer et al. Effect of induced ventricular tachycardia on atrial natriuretic peptide in humans
Kaygisiz et al. Erythropoietin changes contractility, cAMP, and nitrite levels of isolated rat hearts